Global Near-Infrared Fluorescence Imaging System Market: Introduction
Near-infrared fluorescence (NIRF) imaging system is an emerging clinical technology that irradiates near-infrared excitation light, and permits relatively deep photon penetration into tissues when exogenous near-infrared fluorophores are introduced. It is a system that enables the observation of blood flow and lymph flow under the tissue surface by providing surgeons highly specific images of targeted tissue by imaging the near-infrared fluorescence.
Read Report Overview -
https://www.transparencymarketresearch.com/near-infrared-fluorescence-imaging-system-market.html
The imaging system provides an image of a broad area due to the large field of view, such as the abdomen, providing a quick overview and real-time identification of assessing blood flow through blood vessels in an abdominal flap or the gastric tube. Clinical applications of near-infrared fluorescence imaging system are increasing for various surgical procedures. NIRF imaging requires administration of a fluorescence-imaging agent that can be excited at near-infrared (NIR) wavelengths of ≥760 nm.
Fluorescent contrast agents not only provide enhanced contrast but also reveal specific molecular events associated with cancer formation and progression. Indocyanine green fluorescence imaging, enables simple and real-time identification of lymphatic vessels and confirmation of blood flow during surgery. NIRF imaging systems play an important role in cancer surgeries. For instance, Shimadzu Corporation LIGHTVISION is designed to support breast cancer treatment by providing visuals of lymph vessels and blood vessels, based on the detection of near-infrared fluorescent light emitted from indocyanine green.
Request Brochure of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=48507
Key Drivers of Global Near-Infrared Fluorescence Imaging System Market
Rise in Prevalence of Cardiovascular Diseases
In 2016, 17.6 million people died of cardiovascular conditions, worldwide, as compared to 17.9 million in 2015. Cardiovascular diseases (CVDs) are disorders of the heart and the blood vessels. They include coronary heart disease, cerebrovascular disease, and rheumatic heart disease. Cardiovascular diseases is the leading cause of mortality in the U.S., followed closely by cancer and chronic respiratory diseases. According to the report, about 48% of the adult population in the U.S. is living with a form of cardiovascular disease.
Increase in Demand for Imaging
Medical imaging refers to the techniques and processes used to create images of the human body (or parts thereof) for various clinical purposes such as medical procedures and diagnosis or medical science including the study of normal anatomy and function. Increasing applications of computers and developments in image technology has greatly influenced medical imaging in the medical field. Novel macroscopic and molecular imaging techniques are likely to form the cornerstone of personalized diagnosis in the near future.
Request for Custom Research -
https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=48507
North America to Account for Major Share of Global Near-Infrared Fluorescence Imaging System Market
North America is projected to account for a major share of the global near-infrared fluorescence imaging system market during the forecast period. North America is likely to account for a dominant share of the global market, and the market in the region is estimated to expand at a significant pace during the forecast period. Surge in government investments, rise in research and development activities, and increase in the number of alliances among key players in the market drive the market in the region. Moreover, rise in prevalence of cancer in the region has led to an increase in the number of surgeries and demand for NIRF imaging system in North America. Europe accounts for a substantial share of the global near-infrared fluorescence imaging system market. This trend is likely to continue during the forecast period. High capital investments by governments and venture capitalist firms in several countries have attracted key players to the region.
Pre Book Near-Infrared Fluorescence Imaging System Market Report at
https://www.transparencymarketresearch.com/checkout.php?rep_id=48507<ype=S
Key Players Operating in Global Near-Infrared Fluorescence Imaging System Market
The global near-infrared fluorescence imaging system market is highly consolidated owing to the presence of several key players. Leading players operating in the global near-infrared fluorescence imaging system market include:
- Ferring Pharmaceuticals
- Sun Pharma
- Shanghai Soho-Yiming Pharmaceuticals
- EVER Pharma
- Hangzhou Longshine Bio-Tech
- Cayman Chemical
- Neore Pharmaceutical
More Trending Reports by Transparency Market Research –
Viscosupplementation Market:
Vitamin D Testing Market:
About Us
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
